Health & Medicine
FDA Tells Personal Genetic Test 23andMe to Stop Sales
The Food and Drug Administration issued a warning letter to the personal genetic test maker 23andMe, demanding the Google-back company discontinue marketing its signature service until it receives marketing clearance from the agency.
Latest Research Articles
How Sexual Regret Affects Reproduction in Humans
FDA Eases Restrictions on Glaxo Diabetes Drug Avandia
Graphic Pictorial Warnings Reduce Smoking in Canada, Researchers Say US Should Follow Suit
Effectiveness of Antibiotics Boosted by Newly Created Compounds
Steroid Injections During Pregnancy Can Up ADHD Risk
Asparagine found in Meat and Dairy Essential for Brain Development
ADHD Diagnosis and Medication Use Sharply Increased During the Last Decade: CDC
Casual Sex Associated with Depression; Study
Study Explores Fear of Pain
Sugary Drinks Increase Endometrial Cancer Risk in Post Menopausal Women
FDA Approves Johnson & Johnson's Olysio for Hepatitis C Virus Infection Treatment
Stem Cells from the Umbilical Cord Used to Grow Artificial Skin
MOST POPULAR
-
Why Mother Animals Abandon Their Offspring: The Case of Punch, an Infant Macaque
-
Mayon Volcano's 1,000m Ash Plume Signals Escalating Eruption Risk
-
Whales and Sharks in Crisis: Conservation Challenges and Marine Biodiversity Threats
-
Why Do Sinkholes Form? Causes, Common Hotspots, and Land Subsidence Risks
-
From El Niño to La Niña, Climate Cycles Behind Global Weather Extremes
